Companies: 10,795·Total market cap: $144.5T
DMK Pharmaceuticals Corporation

DMK Pharmaceuticals Corporation

DMKPQOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$1010
P/E Ratio
52W High$0.001
52W Low$0.00001

DMK Pharmaceuticals Corporation (DMKPQ) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

DMKPQ · cash on hand · updated Dec 31, 2022

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$1.1M -95.2% vs prior year
FY · as of Dec 31, 2022 · Reported in USD
Cash & Cash Equiv. (CCE)
$1.1M
cashAndCashEquivalents
Short-Term Investments
$30,068
shortTermInvestments
YoY Change vs Prior Year
-95.2%
vs prior fiscal year
Latest Quarter
$6.7M
Q3 2023
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2022

Net cash vs debt

Cash & ST Investments$1.1MCash on Hand
Total Debt$342,562Total Debt
Net Cash / Net Debt+$768,870Net Cash Position
Cash vs Debt Ratio
Cash 76%Debt 24%

DMK Pharmaceuticals Corporation has a net cash position of $768,870, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$1.1M$342,562 = +$768,870

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
DMKPQ annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2022Latest$1.1M-95.2%
Dec 31, 2021$23.3M+244.5%
Dec 31, 2020$6.7M-23.4%
Dec 31, 2019$8.8M-54.3%
Dec 31, 2018$19.3M+5.1%
DMKPQ cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
DMK Pharmaceuticals Corporation
DMK Pharmaceuticals CorporationYOU
DMKPQ
$1.1M110042.8%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

DMK Pharmaceuticals Corporation (DMKPQ) cash on hand as of December 31, 2022 is $1.1M, comprising $1.1M in cash and cash equivalents (CCE) plus $30,068 in short-term investments — reported as DMK Pharmaceuticals Corporation cash and short-term investments on the balance sheet (10-K filing). Also referred to as DMK Pharmaceuticals Corporation cash reserves or cash position.

DMK Pharmaceuticals Corporation annual cash on hand history shows decreased -95.2% in 2022: decreased -95.2% in 2022. DMK Pharmaceuticals Corporation cash reserves in 2022 reflect the company's capital allocation strategy.

DMK Pharmaceuticals Corporation carries total debt of $342,562 against cash of $1.1M, resulting in a net cash position of +$768,870. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

DMKPQ cash on hand · 5 questions

As of December 31, 2022, DMK Pharmaceuticals Corporation (DMKPQ) has $1,111,432 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $1,081,364 in cash and cash equivalents (CCE) plus $30,068 in short-term investments. Latest quarter (September 30, 2023): $6,663,921. Data sourced from the annual 10-K filing via FMP.

DMKPQ cash on handDMKPQ cash reservesDMKPQ cash 2022how much cash does DMKPQ have

Source: FMP /balance-sheet-statement · US GAAP · DMK Pharmaceuticals Corporation · DMK Pharmaceuticals Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2022